Biotech company Prenetics, out of Hong Kong, is going to go public through a SPAC merger with Artisan Acquisition that will value the company at $1.7 billion. Artisan Acquisition is backed by the CEO and Executive Vice Chairman of Hong Kong-listed New World Development, Adrian Cheng. Cheng says that Prenetics was picked for several reasons. … Continue reading “Hong Kong Start-up Prenetics to List in the U.S. Through a SPAC Deal at $1.7B”
